Key Segmentation
By Product Type
-
Infectious Disease RDTs
-
Cardiac Marker RDTs
-
Pregnancy & Fertility RDTs
-
Glucose Monitoring RDTs
-
Others
By Technology
-
Lateral Flow Immunoassays (LFIA)
-
Molecular Rapid Tests
-
Agglutination Assays
-
Others
By Application
-
Infectious Disease Testing
-
Cardiology Testing
-
Pregnancy & Fertility Testing
-
Blood Glucose Monitoring
-
Others
By End-User
-
Hospitals & Clinics
-
Diagnostic Laboratories
-
Home Care Settings
-
Others
By Distribution Channel
-
Hospital Pharmacies
-
Retail Pharmacies
-
Online Pharmacies
-
Direct Tenders (Government & NGOs)
-
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
North America dominated with a 46.84% share in 2025, while Asia-Pacific is the fastest-growing region, expected to expand at a CAGR of 9.74% during 2026–2035.
Infectious Disease RDTs dominated with a 52.75% share in 2025, while Infectious Disease RDTs s are also projected to grow at the fastest CAGR of 8.12% during 2026–2035.
Growth is driven by rising prevalence of infectious diseases, increasing demand for point-of-care testing, expanding adoption of home-based diagnostic kits, and advancements in rapid diagnostic technologies.
The market is valued at USD 32.88 Billion in 2025 and is projected to reach USD 67.83 Billion by 2035.
The Rapid diagnostic tests Market is projected to grow at a CAGR of 7.62% during 2026–2035.